THÔNG TIN TÀI LIỆU
types A and B Niemann Pick disease J Pediatr 2004;145(1):77–81 103 Gaucher PCE De L'epitheliome Primitif De La Rate [These de Paris] 1882 104 Abrahamov A, Elstein D, Gross-Tsur V, et al Gaucher's disease variant characterised by progressive calcification of heart valves and unique genotype Lancet 1995;346:10001003 105 Saradar M, Atalay S, Koỗak N, ệzkutlu S Gaucher's disease with mitral and aortic involvement: echocardiographic findings Pediatr Cardiol 1991;13:56–58 106 George R, McMahon J, Lytle B, Clark B, Lichtin A Severe valvular and aortic arch calcification in a patient with Gaucher's disease homozygous for the d409h mutation Clin Genet 2001;59(5):360–363 107 Linari S, Castaman G Clinical manifestations and management of gaucher disease Clin Cases Miner Bone Metab 2015;12(2):157–164 108 Eng CM, Germain DP, Banikazemi M, et al Fabry disease: guidelines for the evaluation and management of multi-organ system involvement Genet Med 2006;8(9):539–548 109 Desnick RJ, Blieden LD, Sharp HL, Moller JH Cardiac valvular anomalies in Fabry's disease: clinical, morphologic and biochemical studies Circulation 1976;54:818–825 110 Mehta J, Tuna N, Moller JH, Desnick RJ Electrocardiographic and vectorcardiographic abnormalities in Fabry's disease Am Heart J 1977;93:699–705 111 Bass JL, Shrivastava S, Grabowski GA, Desnick RJ, Moller JH The M-mode echocardiogram in Fabry's disease Am Heart J 1980;100:807–812 112 Beck M Agalsidase alfa—a preparation for enzyme replacement therapy in Anderson-fabry disease Expert Opin Investig Drugs 2002;11(6):851–858 113 Lidove O, Joly D, Barbey F, et al Clinical results of enzyme replacement therapy in fabry disease: a comprehensive review of the literature Int J Clini Pract 2007;61(2):293–302 114 Yuasa T, Takenaka T, Higuchi K, et al Fabry disease J Echocardiogr 2017 115 Guertl B, Noehammer C, Hoefler G Metabolic cardiomyopathies Int J Exp Pathol 2000;81(6):349–372 116 Gilbert EF, Varakis J, Opitz JM, et al Generalized gangliosidosis type II (juvenile GM1 gangliosidosis) A pathological, histochemical and ultrastructural study Z Kinderheilkd 1975;120(3):151–180 117 Gillan JE, Lowden JA, Gaskin K, Cutz E Congenital scites as a presenting sign of lysosomal storage disease J Pediatr 1984;104(2):225–231 118 Rosenburg H, Frewen TC, Li MD, et al Cardiac involvement in diseases characterized by βgalactosidase deficiency J Pediatr 1985;106:78–80 119 Callahan JW Molecular basis of GM1 gangliosidosis and morquio disease, type B Structure-function studies of lysosomal betagalactosidase and the non-lysosomal betagalactosidase-like protein Biochim Biophys Acta 1999;1455(2–3):85–103 120 Brady RO Emerging strategies for the treatment of hereditary metabolic storage disorders Rejuvenation Res 2006;9(2):237–244 121 Suzuki Y Beta-galactosidase deficiency: an approach to chaperone therapy J Inherit Metab Dis 2006;29(2–3):471–476 122 Matsuda J, Suzuki O, Oshima A, et al Chemical chaperone therapy for brain pathology in G(M1)- gangliosidosis Proc Natl Acad Sci USA 2003;100(26):15912–15917 123 Sandhoff K, Harzer K Gangliosides and gangliosidoses: principles of molecular and metabolic pathogenesis J Neurosci 2013;33(25):10195–10208
Ngày đăng: 22/10/2022, 12:58
Xem thêm: